RGABX
Price
$76.42
Change
+$0.41 (+0.54%)
Updated
Sep 11 closing price
Net Assets
353.07B
RPNRX
Price
$14.88
Change
+$0.15 (+1.02%)
Updated
Sep 11 closing price
Net Assets
3.73M
Interact to see
Advertisement

RGABX vs RPNRX

RGABX vs RPNRX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 353B vs. RPNRX (3.73M). RGABX (0.00) and RPNRX (0.00) have matching dividends . RGABX was incepted earlier than RPNRX: RGABX (24 years) vs RPNRX (3 years). RPNRX (2.22) is less costly to investors than RGABX (1.38). RPNRX is a more actively managed with annual turnover of: 75.00 vs. RGABX (32.00). RGABX has a lower initial minimum investment than RPNRX: RGABX (250) vs RPNRX (1000). RPNRX annual gain was more profitable for investors over the last year : 4.17 vs. RGABX (-1.94).
RGABXRPNRXRGABX / RPNRX
Total Expense Ratio1.381.25110%
Annual Report Gross Expense Ratio1.382.2262%
Fund Existence24 years3 years-
Gain YTD8.4897.675111%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets353B3.73M9,473,967%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.944.17-46%
Returns for 3 years35.88N/A-
Returns for 5 years5.33N/A-
Returns for 10 years86.62N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFCWX18.010.18
+1.01%
American Century Focused Intl Gr R
FPHAX33.90N/A
N/A
Fidelity Select Pharmaceuticals Port
LLSCX26.65N/A
N/A
Longleaf Partners Small-Cap
RTNSX16.22N/A
N/A
Russell Inv Tax-Managed Intl Eq S
UPAAX22.63N/A
N/A
Upright Assets Allocation Plus